-
摘要药品专利保护制度的日趋完善，对公共健康问题造成巨大影响。随着全球化趋势的日益加强，发达国家为了更好地保护其国内的药品研究成果，不断提出健全药品专利保护制度，主要就是通过提高TRIPS协议中有关药品专利保护的相关水平从而整体提高全球特别是发展中国家以及最不发达国家的药品专利保护水平。但是，这对发展中国家以及最不发达国家而言不仅是对其制度的挑战，更是对其公共健康问题的冲击。一方面发达国家希望其国民的药品研究成果获得最完善的保护从而增加其经济收益，另一方面发展中国家以及最不发达国家则希望能够提高药品的可及性从而缓解其国内严峻的公共问题形势。本文旨在分析TRIPS协议、多哈宣言等国际文件以及对比国内外处理该问题的异同，提出平衡药品专利保护与公共健康两者之间利益的途径。45488
- 上一篇：促进城乡公共服务均等化的地方财政体制改革研究
- 下一篇：信息网络传播权的法律保护
毕业论文关键词：药品专利 公共健康 TRIPS协议 多哈宣言
Abstract Improvement of pharmaceutical patent protection system makes a huge impact on public health problem. With the trend of growing globalization,in order to protect its domestic pharmaceutical research fruit better, the developed countries put forward a sound about promoting pharmaceutical patent protection system,which is mainly by improving relevant levels on pharmaceutical patent protection in TRIPS agreement so as to improve the pharmaceutical patent protection level of the world especially developing countries and least developed countries . But for developing countries and least developed countries.that is not only a challenge to their legal system, but also impacts on the public health problems. On the one hand, the developed country hopes that its national pharmaceutical research fruit can get the perfect protection for the sake of increasing its economic benefits;on the other hand, developing countries and least developed countries, hopes to improve the drug accessibility to ease the domestic serious public problem. The purpose of this paper is to analyzes the TRIPS agreement, the doha declaration and other international documents and comparing the similarities and differences between at home and abroad dealing with the problem, then put forward my own advice about balance between pharmaceutical patent protection and public health benefits.
Key words： pharmaceutical patent public health TRIPS Agreement
Doha Declaration
目 录
摘 要Ⅰ
AbstractⅡ
一、药品专利权保护制度与公共健康的关系1
（一)药品专利权保护制度与公共健康冲突的案例1
（二)药品专利权保护制度对公共健康的影响2
(三）药品专利权保护制度与公共健康冲突的根源4
二、与公共健康有关的药品专利权保护制度5
(一）TRIPS协议的规定 6
（二)《多哈宣言》的规定7
（三)外国药品专利权保护制度9 三、中国药品专利权保护制度与公共健康的冲突10
（一)中国药品专利保护制度与公共健康冲突现状 10
（二)中国药品专利保护制度与公共健康冲突协调12
四、解决药品专利权保护制度与公共健康冲突的建议13
（一)TRIPS协议的完善13
（二)《多哈宣言》的完善14
（三)Bolar例外的实施15
（四)发达国家与发展中国家的协调15
结 语16
参考文献17
致 谢18
浅析药品专利权保护制度与公共健康
目前，药品专利保护制度日趋完善，引发了药品专利保护权与公共健康问题的冲突，如何平衡两者之间的利益关系，即既要保护药品研发者的专利权，也要让公共健康得到保障，是需要迫切解决的问题。